{
  "id": 6427104,
  "title": "STAT+: Pharmalittle: We’re reading about an AstraZeneca COPD win, the FDA filling key jobs, and more",
  "url": "https://urgent.news/2026/09/09/stat-pharmalittle-were-reading-about-an-astrazeneca-copd-win-the-fda",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-09T13:15:57.000Z",
  "source": {
    "name": "STAT News",
    "slug": "stat-news",
    "url": "https://www.statnews.com/pharmalot/2026/09/09/astrazeneca-copd-win-fda-filling-key-jobs/"
  },
  "original_language": "en",
  "account": "Good morning and welcome to the middle of the week. Make a note to enjoy a cuppa stimulation later, as we present the latest news. Today's featured beverage is ginseng peach, a pantry favorite. Here are the latest tidbits to help you on your way. We hope you succeed in conquering the world and have a wonderful day.\n\nIn significant COPD news, an AstraZeneca drug showcased promising results in late-stage trials, potentially marking a new option for millions of patients. The injectable drug showed promise in reducing dangerous flare-ups, which can severely impact those with the debilitating lung condition. Notably, this breakthrough comes after recent setbacks for AstraZeneca, particularly with a heart disease drug. Analysts project that if approved, the treatment could generate billions in annual sales for AstraZeneca, not just for COPD but also for conditions like asthma.\n\nMeanwhile, the U.S. Food and Drug Administration finalized four key leadership roles on Tuesday. The appointments include Michael Davis, a psychiatrist who will head the Center for Drug Evaluation and Research; Karim Mikhail, a former Merck official who will lead the Center for Biologics Evaluation and Research; and Bret Koplow, an attorney with over a decade of experience at the FDA who will oversee the Center for Tobacco Products. All three officials will serve in their new roles permanently.",
  "summary": "An AstraZeneca drug reduced the dangerous flare-ups that worsen COPD in a pair of late-stage trials",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}